SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — James Madison Synthetic CCD

PatientJames Madison
Date of birth2003-03-16
IdentifiersMRN HR-EN007-SYN; SSN (made up) 000-07-2618
Document date2026-11-01
AuthorJosiah Pembroke-Achebe, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Primary care visit for two years of recurrent sudden episodes of unresponsiveness, with low mood and anxiety, on levetiracetam started without a diagnosis. Concerns: For two years he has had sudden spells in which his mind seems to stop; he is afraid of having one in public or at the wheel; He feels low and worried, and does not expect to live long; He wants to know whether he has epilepsy and whether he can study law and take part in public life. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Levetiracetam 500 mg oral tablet, one tablet twice daily, started at an emergency department visit four months before intake for possible seizures, without an EEGOne tablet twice dailyOral route2025-12-02 to 2026-04-30completedS
Levetiracetam 500 mg oral tablet, taper: half a tablet (250 mg) twice daily for two weeks, then half a tablet at night for one week, then stopHalf a tablet twice daily for two weeks, then half a tablet at night for one week, then stopOral route2026-04-30 to 2026-05-21completedS
Sertraline 50 mg oral tablet, half a tablet (25 mg) each morning for one week, then one tablet (50 mg) each morningHalf a tablet each morning for one week, then one tablet each morningOral route2026-06-11activeS
Ondansetron 4 mg orally disintegrating tablet, one tablet every 8 hours as needed for vomiting, for up to three daysOne tablet every 8 hours as needed for vomiting, up to three daysOral route2026-08-20 to 2026-08-23completedS

Procedures

ProcedureDatesStatusEvidence
Resting 12-lead ECG: sinus rhythm at 76 per minute; normal PR, QRS, and QTc (404 ms); no pre-excitation, Brugada pattern, or heart block2026-04-07 to 2026-04-07completedS
MRI of the brain with an epilepsy protocol (3 tesla, thin coronal sections through the hippocampi): normal; no hippocampal sclerosis, cortical malformation, or other lesion2026-04-14 to 2026-04-14completedS
Inpatient video-EEG monitoring for 72 hours with sleep deprivation, hyperventilation, and photic stimulation, levetiracetam continued: two habitual events captured (2 minutes 40 seconds and 6 minutes), each with eyes closed and resisting opening, fluctuating unresponsiveness, and slow side-to-side head movements, during which the EEG showed a continuous normal waking posterior rhythm with no ictal or postictal change; normal interictal EEG awake and asleep; he confirmed both events as typical2026-04-27 to 2026-04-30completedS

Immunizations

DateVaccineStatusEvidence
2015-03-20Tdap vaccine, adolescent dosecompletedS
2015-09-18HPV vaccine, 9-valent, two-dose series completedcompletedS
2026-07-16Tdap vaccine, adult boostercompletedS
2026-09-24Influenza vaccine, 2026-2027 seasoncompletedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
ChildhoodA frail and sickly child, by the Library of Congress's accountD (CLM-0003)
1771 to 1772Infirm health at college, which he put down to doing two years' work in one; for months he slept only three hours a nightD (CLM-0004)
November 1772Wrote that he felt dull and infirm and did not expect a long or healthy lifeD (CLM-0005)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
For two years he has had sudden spells in which his mind seems to stop; he is afraid of having one in public or at the wheelactiveS
He feels low and worried, and does not expect to live longactiveS
He wants to know whether he has epilepsy and whether he can study law and take part in public lifeactiveS

Assessment

Most recent measures: Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 6 on 2026-09-24; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 7 on 2026-09-24; Total score [AUDIT-C] 1 on 2026-07-16; Hemoglobin [Mass/volume] in Blood 14.9 on 2026-04-07; Leukocytes [#/volume] in Blood by Automated count 6.4 on 2026-04-07; Platelets [#/volume] in Blood by Automated count 231 on 2026-04-07; Sodium [Moles/volume] in Serum or Plasma 139 on 2026-04-07; Potassium [Moles/volume] in Serum or Plasma 4.2 on 2026-04-07; Creatinine [Mass/volume] in Serum or Plasma 0.86 on 2026-04-07; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 125 on 2026-04-07; Glucose [Mass/volume] in Serum or Plasma 84 on 2026-04-07; Calcium [Mass/volume] in Serum or Plasma 9.6 on 2026-04-07; Thyrotropin [Units/volume] in Serum or Plasma 1.8 on 2026-04-07; Q-T interval corrected 404 on 2026-04-07 [S]

Strengths and supports: engagement in care [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Recurrent sudden episodes of unresponsiveness for two years, two or three a month: he 'blanks out', stops speaking, slumps or sinks to the floor with his eyes closed for two to ten minutes, and afterwards is tearful and tired, with no tongue biting, incontinence, or injury; first during a period of overwork and little sleep at college; with low mood and anxiety; unchanged on levetiracetam; under evaluation for epilepsy, functional (dissociative) seizures, syncope, and other causesresolvedconfirmed R40.4S — Synthetic presenting problem echoing his documented overwork, infirm health, and low spirits, and the later accounts of sudden attacks; superseded by the diagnosis at the second visit.
Taking an antiseizure medicine (levetiracetam) started without a confirmed diagnosis of epilepsyresolvedconfirmed Z79.899S — Synthetic medication problem for teaching about avoiding unneeded antiseizure medicines; resolved when the medicine was stopped.
Functional/dissociative seizures (psychogenic nonepileptic seizures), documented by video-EEG: two habitual events captured with eyes closed and resisting opening, fluctuating unresponsiveness, and a normal waking EEG throughout, with no ictal or postictal change; normal interictal EEG and brain MRI; epilepsy and syncope excludedactiveconfirmed F44.5S — Synthetic modern diagnosis. His infirm health, overwork, and low spirits in youth are documented (D); retrospective explanations of his later attacks, including epilepsy, are disputed (R). This record does not assert what his attacks were.
Generalized anxiety disorder: worry about his future, his health, and his studies most days for more than a year, with restlessness, poor sleep, and muscle tension (GAD-7 14 at intake)activeconfirmed F41.1S — Synthetic diagnosis made at the neuropsychiatric assessment during video-EEG monitoring.
Major depressive disorder, single episode, moderate: low mood, loss of interest, poor sleep and concentration, and a sense that he will not live long, for about eighteen months (PHQ-9 13 at intake); no suicidal ideation or intentactiveconfirmed F32.1S — Synthetic diagnosis echoing, without asserting, his documented letter expecting an early death.
Acute viral gastroenteritis with mild dehydration, a day of vomiting and diarrhea after a household outbreak; one functional seizure the evening before the visit; resolvedresolvedconfirmed A08.4S — Synthetic intercurrent illness at an unscheduled visit; it echoes, without asserting, the 'bilious' illnesses recorded in his later life (CLM-0010).

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-04-07Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]13{score}S
2026-04-07Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]14{score}S
2026-04-07Total score [AUDIT-C]1{score}S
2026-04-07Hemoglobin [Mass/volume] in Blood14.9g/dL13.2-16.6 g/dLNormalS
2026-04-07Leukocytes [#/volume] in Blood by Automated count6.410*3/uL3.4-9.6 10*3/uLNormalS
2026-04-07Platelets [#/volume] in Blood by Automated count23110*3/uL150-400 10*3/uLNormalS
2026-04-07Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-04-07Potassium [Moles/volume] in Serum or Plasma4.2mmol/L3.5-5.1 mmol/LNormalS
2026-04-07Creatinine [Mass/volume] in Serum or Plasma0.86mg/dL0.74-1.35 mg/dLNormalS
2026-04-07Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M125mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-04-07Glucose [Mass/volume] in Serum or Plasma84mg/dL70-99 mg/dLNormalS
2026-04-07Calcium [Mass/volume] in Serum or Plasma9.6mg/dL8.6-10.3 mg/dLNormalS
2026-04-07Thyrotropin [Units/volume] in Serum or Plasma1.8m[IU]/L0.4-4 mIU/LNormalS
2026-04-07Q-T interval corrected404msBelow 450 ms is normal for a manNormalS
2026-04-30Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]12{score}S
2026-04-30Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]13{score}S
2026-06-11Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]11{score}S
2026-06-11Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]12{score}S
2026-07-16Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]8{score}S
2026-07-16Total score [AUDIT-C]1{score}S
2026-09-24Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S
2026-09-24Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]7{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-04-07Body height168cmS
2026-04-07Body weight54kgS
2026-04-07Body mass index (BMI) [Ratio]19.1kg/m2S
2026-04-07Systolic blood pressure112mm[Hg]S
2026-04-07Diastolic blood pressure70mm[Hg]S
2026-04-07Heart rate76/minS
2026-04-07Respiratory rate14/minS
2026-04-07Body temperature36.7CelS
2026-04-07Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-04-30Body height168cmS
2026-04-30Body weight54.2kgS
2026-04-30Body mass index (BMI) [Ratio]19.2kg/m2S
2026-04-30Systolic blood pressure110mm[Hg]S
2026-04-30Diastolic blood pressure68mm[Hg]S
2026-04-30Heart rate72/minS
2026-04-30Respiratory rate14/minS
2026-04-30Body temperature36.6CelS
2026-04-30Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-06-11Body height168cmS
2026-06-11Body weight54.6kgS
2026-06-11Body mass index (BMI) [Ratio]19.3kg/m2S
2026-06-11Systolic blood pressure112mm[Hg]S
2026-06-11Diastolic blood pressure70mm[Hg]S
2026-06-11Heart rate74/minS
2026-06-11Respiratory rate14/minS
2026-06-11Body temperature36.6CelS
2026-06-11Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-07-16Body height168cmS
2026-07-16Body weight55kgS
2026-07-16Body mass index (BMI) [Ratio]19.5kg/m2S
2026-07-16Systolic blood pressure114mm[Hg]S
2026-07-16Diastolic blood pressure72mm[Hg]S
2026-07-16Heart rate70/minS
2026-07-16Respiratory rate14/minS
2026-07-16Body temperature36.6CelS
2026-07-16Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-08-20Body height168cmS
2026-08-20Body weight53.6kgS
2026-08-20Body mass index (BMI) [Ratio]19kg/m2S
2026-08-20Systolic blood pressure104mm[Hg]S
2026-08-20Diastolic blood pressure64mm[Hg]S
2026-08-20Heart rate102/minS
2026-08-20Respiratory rate16/minS
2026-08-20Body temperature37.7CelS
2026-08-20Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-09-24Body height168cmS
2026-09-24Body weight55.2kgS
2026-09-24Body mass index (BMI) [Ratio]19.6kg/m2S
2026-09-24Systolic blood pressure112mm[Hg]S
2026-09-24Diastolic blood pressure70mm[Hg]S
2026-09-24Heart rate68/minS
2026-09-24Respiratory rate14/minS
2026-09-24Body temperature36.6CelS
2026-09-24Oxygen saturation in Arterial blood by Pulse oximetry99%S

Encounters

DatePurposeStatusProvenance
2026-04-07Primary care visit for two years of recurrent sudden episodes of unresponsiveness, with low mood and anxiety, on levetiracetam started without a diagnosisfinishedS
2026-04-30Discharge-day review after video-EEG monitoring: diagnosis, its explanation, and the epilepsy and functional neurological disorder consultationfinishedS
2026-06-11Six-week review after the diagnosis: levetiracetam withdrawn, psychotherapy under way, mood and anxietyfinishedS
2026-09-24Three-month review after completing psychotherapy: events, mood, driving, and his studiesfinishedS
2026-07-16Preventive health visit at 23finishedS
2026-08-20Same-day sick visit for viral gastroenteritisfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Diagnostic workup: a detailed history including a witness account or phone video if available, ECG, blood count, metabolic panel, TSH, brain MRI with an epilepsy protocol, and inpatient video-EEG monitoring to capture his habitual events; levetiracetam continued unchanged until the evaluation is completecompletedGL-ILAE-PNES-2013, GL-ILAE-FDS-2025, GL-ILAE-SZ-2017, GL-ILAE-DEF-2014S
Safety now: no driving until the evaluation is complete and the neurologist advises; showers rather than baths, no swimming alone or working at heights; seizure first aid for the people he lives and works nearcompletedGL-AAN-DRIVE-2025, GL-CDC-SZFIRSTAIDS
Suicide risk assessment with a written safety plan: warning signs, coping steps, people to contact, the clinic number, and the 988 Suicide & Crisis Lifeline; the rifle locked with the ammunition stored separately; safety reviewed at every visitcompletedGL-SUICIDE-2024, GL-CMID-2026S
Neurology consultation (epilepsy and functional neurological disorder) with admission for video-EEG monitoring, on the diagnosis, the antiseizure medicine, and treatmentcompletedGL-ILAE-PNES-2013, GL-ILAE-FDS-2025, GL-ILAE-SZ-2017S
Explaining the diagnosis: functional/dissociative seizures named and explained in person and in writing as real, common, and not epilepsy or feigning; how the brain can switch off awareness under strain; why antiseizure medicines do not help; that treatment works; a reliable written and online resource; a follow-up appointment to answer questionscompletedGL-HALLPATCH-2010, GL-STONE-2016, GL-ILAE-FDS-2025S
Levetiracetam withdrawn: 250 mg twice daily for two weeks, 250 mg at night for one week, then stopped; no driving during the tapercompletedGL-ILAE-PNES-2013, GL-ILAE-FDS-2025, GL-ILAE-SZ-2017, GL-AAN-DRIVE-2025S
CBT-informed psychotherapy for functional seizures: twelve weekly sessions with a psychologist experienced in functional neurological disorder, with an event diary, recognition of warning sensations, grounding techniques, work on avoidance, sleep, and worry, and a relapse-prevention plancompletedGL-LAFRANCE-2014, GL-CODES-2020, GL-ILAE-PNES-2013, GL-ILAE-FDS-2025, GL-ILAE-SZ-2017S
Measurement-based care for depression and anxiety: PHQ-9 and GAD-7 at least monthly during treatment; psychotherapy, an SSRI such as sertraline, or both, by shared decision once the cause of the events is clearcompletedGL-CMID-2026, GL-MDD-2022S
Studies and daily life: a regular sleep window of at least seven hours, study blocks with breaks, academic accommodations for testing (extra breaks), and a return to civic meetings with a friend who knows the first-aid plancompletedGL-ILAE-PNES-2013, GL-ILAE-FDS-2025, GL-ILAE-SZ-2017, GL-LAFRANCE-2014, GL-CODES-2020S
Driving: may resume once free of events for at least three months and with the neurologist's agreement, following state licensing rules and the AAN 2025 positioncompletedGL-AAN-DRIVE-2025S

Goals

GoalTargetStatusOutcomeProvenance
Cause of the episodes established by the second visit2026-04-30completedFunctional/dissociative seizures documented by video-EEG; epilepsy and syncope excludedS
Antiseizure medicine stopped safely2026-06-11completedLevetiracetam tapered over three weeks and stopped, with no change in events and less irritabilityS
Events reduced by at least half, then free of events for three months2026-12-31activeFrom two or three a month to one in the last two months; none for five weeksS
Depression and anxiety improved by at least 50 percent (PHQ-9 and GAD-7)2026-12-31activePHQ-9 13 to 6 and GAD-7 14 to 7S
No suicidal thoughts2026-12-31activeNone at any visitS

Functional Status

Mental Status

Structured synthetic safety assessment on 2026-04-07: current ideation absent, intent absent, plan absent. No suicidal ideation, intent, plan, or behavior (C-SSRS screen negative; PHQ-9 item 9 scored 0); a fatalistic sense that he will not live long, without any wish to die. Moderate depression and anxiety with recurrent events raise risk, so: outpatient care with a written safety plan, the 988 Suicide & Crisis Lifeline and the clinic number, the rifle locked and the ammunition stored separately, and safety review at every visit [S]